¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sclerosing fibrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • subepidermal nodular fibrosis
    Ç¥ÇǹذáÀý¼¶À¯Áõ
  • submucous fibrosis
    Á¡¸·¹Ø¼¶À¯Áõ
  • sclerosing
    °æÈ­-
  • sclerosing adenosis
    °æÈ­»ùÁõ, °æÈ­¼±Áõ
  • sclerosing agent
    °æÈ­Á¦
  • sclerosing angioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°, °æÈ­´ã°ü¿°
  • sclerosing epithelial hamartoma
    °æÈ­Ç¥Çǰú¿ÀÁ¾
  • sclerosing gastritis
    °æÈ­À§¿°
  • sclerosing hemangioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing inflammation
    °æÈ­¿°Áõ
  • sclerosing keratitis
    °æÈ­°¢¸·¿°
  • sclerosing liposarcoma
    °æÈ­Áö¹æÀ°Á¾
  • sclerosing mastoiditis
    °æÈ­²ÀÁöµ¹±â¿°, °æÈ­À¯µ¹¿°
  • sclerosing osteogenic sarcoma
    °æÈ­»ÀÀ°Á¾, °æÈ­°ñÀ°Á¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing angioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°
  • subacute sclerosing encephalitis
    ¾Æ±Þ¼º°æÈ­³ú¿°
  • sclerosing gastritis
    °æÈ­À§¿°
  • sclerosing hemangioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing histoplasmosis
    °æÈ­È÷½ºÅäÇö󽺸¶Áõ
  • sclerosing epithelial hamartoma
    °æÈ­Ç¥Çǰú¿ÀÁ¾
  • sclerosing inflammation
    °æÈ­¿°Áõ
  • sclerosing keratitis
    °æÈ­°¢¸·¿°
  • radial sclerosing lesion
    ¹æ»ç»ó°æÈ­º´ÅÍ
  • sclerosing lipogranuloma
    °æÈ­Áö¹æÀ°¾ÆÁ¾
  • sclerosing liposarcoma
    °æÈ­Áö¹æÀ°Á¾
  • sclerosing mastoiditis
    °æÈ­²ÀÁö¿°
  • sclerosing myelitis
    °æÈ­Ã´¼ö¿°
  • subacute sclerosing panencephalitis
    ¾Æ±Þ¼º°æÈ­¹ü³ú¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • preretinal fibrosis
    ¸Á¸·¾Õ¼¶À¯Áõ
  • preretinal macular fibrosis
    ¸Á¸·¾ÕȲ¹Ý¼¶À¯Áõ
  • progressive nodular fibrosis of the skin
    ÁøÇ༺ °áÀý ÇǺΠ¼¶À¯Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ(øËàéë«ñø).
  • pulmonary fibrosis
    Æó¼¶À¯Áõ(øËàéë«ñø)
  • pulmonary fibrosis
    Æó¼¶À¯È­
  • radiation fibrosis
    ¹æ»ç ¹æ»ç¼±¼¶À¯Áõ(Û¯ÞÒàÊ àéë«ñø).
  • radiation fibrosis
    ¹æ»ç¼± ¼¶À¯Áõ(Û¯ÞÒàÊ àéë«ñø)
  • radiation fibrosis
    ¹æ»ç¼±¼¶À¯Áõ
  • radiation fibrosis of lung
    ¹æ»ç¼±Æó¼¶À¯Áõ(Û¯ÞÒàÊøËàéë«ñø).
  • radiation fibrosis of lung
    ¹æ»ç¼±Æó¼¶À¯Áõ(Û¯ÞÒàÊøËàéë«ñø)
  • reactive fibrosis
    ¹ÝÀÀ¼º ¼¶À¯È­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing adenosis,of breast
    À¯¹æÀÇ(êáÛ®¡­)
  • sclerosing agent
    °æÈ­¾à(Ìãûùå·).
  • sclerosing angioma
    °æÈ­¼º ¸Æ°üÁ¾ (¡­ØæÎ·ðþ)
  • sclerosing basal cell carcinoma
    °æÈ­ ±âÀú¼¼Æ÷¾Ï
  • sclerosing cholangitis
    °æÈ­¼º´ãµµ¿°.
  • sclerosing cholangitis
    °æÈ­¼º ´ãµµ¿°
  • sclerosing epithelial hamartoma
    °æÈ­ Ç¥Çǰú¿ÀÁ¾
  • sclerosing gastritis
    °æÈ­¼º À§¿°(¡­êÖæú).
  • sclerosing gastritis
    °æÈ­¼º À§¿°(¡­êÖæú)
  • sclerosing hemangioma
    °æÈ­ Ç÷°üÁ¾
  • sclerosing hemangioma
    °æÈ­¼º Ç÷°üÁ¾(¡­úìηðþ)
  • sclerosing histoplamosis
    °æÈ­¼º È÷½ºÅäÇö󽺸¶Áõ(¡­)ñø
  • sclerosing inflammation
    °æÈ­¼º ¿°Áõ(¡­æúñø)
  • sclerosing keratitis
    °æÈ­°¢¸·¿° (¡­ÊÇØ¯æú).
  • sclerosing keratitis
    °æÈ­¼º °¢¸·¿° (¡­ÊÇØ¯æú)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SSPE Subacute Sclerosing Pan-Encephalitis
ASHN acute sclerosing hyaline necrosis
FSGN focal sclerosing glomerulonephritis
NSHD nodular sclerosing Hodgkin disease
PSC patient services coordination; Porter-Silber chromogen; posterior subcapsular cataract; primary scle...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SC sclerosing cholangitis
CHF Congenital hepatic fibrosis
CF cvstic fibrosis
CFTR Cystic Fibrosis Transmembrane Conductance Regulator
CFTR Cystic Fibrosis Transmembrane Conductance Regulator Gene
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subepidermal nodular fibrosis
    Ç¥ÇÇÇÏ °áÀý¼º ¼¶À¯Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
sclerosing therapy A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
subacute sclerosing leukoencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
subacute sclerosing panencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
focal sclerosing glomerulopathy Focal, segmental glomerulosclerosis reported in adults and children with normal serum complement, progressing to chronic glomerulonephritis.
(05 Mar 2000)
African endomyocardial fibrosis Fibrosis of the inner layers of the myocardium, often including the endocardium, causing diastolic restriction of the heart; indigenous to East Africa.
(05 Mar 2000)
radiation fibrosis The formation of scar tissue as a result of radiation therapy to the lung.
(12 Dec 1998)
mediastinal fibrosis <radiology> Histoplasmosis most common cause, can cause superior vena cava obstruction
(12 Dec 1998)
replacement fibrosis The formation of fibrous tissue that occupies sites where various other cells and tissues have become atrophied, or degenerated and necrotic.
(05 Mar 2000)
retroperitoneal fibrosis <radiology> Ureters tapered or obstructed, most severe at L4-5, ureters deviated medially, Treatment: symptomatic; steroids have ? long-term benefit Differential diagnosis: malignancy, lymphoma (especially Hodgkin's), metastasis from colon and breast, retroperitoneal sarcoma, drugs, methysergide (Sansert), haemorrhage, aortic aneurysm, trauma or surgery, inflammation, Crohn's disease, diverticulitis, pancreatitis, extravasated urine, radiation
(12 Dec 1998)
pericentral fibrosis Fibrosis occurring around the central veins in the hepatic lobules.
(05 Mar 2000)
perimuscular fibrosis Fibrosis in the outer media of arteries, usually the renal arteries of young women, where it causes segmental stenosis and hypertension; a variety of fibromuscular dysplasia.
Synonym: subadventitial fibrosis.
(05 Mar 2000)
pipestem fibrosis A characteristic pipe-shaped fibrosis formed around hepatic portal veins in some cases of long-continued heavy infection with Schistosoma mansoni; thought to be induced by the presence of large numbers of schistosome eggs in the hepatic tissues.
Synonym: Symmers' clay pipestem fibrosis, Symmers' fibrosis.
(05 Mar 2000)
congenital fibrosis of the extraocular muscles An autosomal dominant disorder associated with blepharoptosis and absence of eye movements.
(05 Mar 2000)
cystic fibrosis <chest medicine> A generalised disorder of infants, children and young adults, in which there is widespread dysfunction of the exocrine glands, characterised by signs of chronic pulmonary disease (due to excess mucus production in the respiratory tract), pancreatic deficiency, abnormally high levels of electrolytes in the sweat and occasionally by biliary cirrhosis. There is an ineffective immunologic defense against bacteria in the lungs.
Pathologically, the pancreas shows obstruction of the pancreatic ducts by amorphous eosinophilic concretions, with consequent deficiency of pancreatic enzymes, resulting in steatorrhoea and azotorrhoea and intestinal malabsorption. The degree of involvement of organs and glandular systems may vary greatly, with consequent variations in the clinical picture.
Inheritance: autosomal recessive.
(13 Nov 1997)
cystic fibrosis antigen Now known to be MRP 8.
See: calgranulins.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á